Production (Stage)
AbbVie Inc.
ABBV
$183.26
$0.720.39%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.65% | 4.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.65% | 4.44% | |||
| Cost of Revenue | -8.96% | 4.49% | |||
| Gross Profit | -12.75% | 4.42% | |||
| SG&A Expenses | 11.64% | -27.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.96% | -6.92% | |||
| Operating Income | -26.66% | 32.35% | |||
| Income Before Tax | 173.20% | -208.88% | |||
| Income Tax Expenses | 116.56% | -531.92% | |||
| Earnings from Continuing Operations | 5,704.35% | -101.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -400.00% | 133.33% | |||
| Net Income | 5,945.45% | -101.41% | |||
| EBIT | -26.66% | 32.35% | |||
| EBITDA | -20.15% | 21.97% | |||
| EPS Basic | 4,087.29% | -102.06% | |||
| Normalized Basic EPS | -31.12% | 32.01% | |||
| EPS Diluted | 3,950.27% | -102.13% | |||
| Normalized Diluted EPS | -31.28% | 32.23% | |||
| Average Basic Shares Outstanding | -0.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.17% | -0.17% | |||
| Dividend Per Share | 0.00% | 5.81% | |||
| Payout Ratio | 1.02% | -71.98% | |||